| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23.8B | $21.5B | $19.4B | $17.6B | $15.8B | $3.4B | $3.0B | $2.5B |
| Cost of Revenue | $2.6B | $2.4B | $2.4B | $2.2B | $1.9B | $0.4B | $1.7B | $1.2B |
| Gross Profit | $21.2B | $19.1B | $17.1B | $15.4B | $13.9B | $3.0B | $2.5B | $2.1B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $8.7B | $6.7B | $6.7B | $6.1B | $5.8B | $4.2B | $3.3B | $2.8B |
| Net Income | $7.1B | $5.6B | $5.4B | $4.8B | $4.8B | $2.3B | $0.9B | $0.7B |
| EPS (Basic) | $16.73 | $12.43 | $11.87 | $10.13 | $10.10 | $4.69 | $1.76 | $1.39 |
| EPS (Diluted) | $16.70 | $12.36 | $11.82 | $10.10 | $10.02 | $4.64 | $1.74 | $1.37 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.5B | $30.2B | $29.8B | $27.2B | $27.2B | $24.3B | $20.8B | $18.8B |
| Current Assets | $10.2B | $11.2B | $11.1B | $9.0B | $8.7B | $8.1B | $6.5B | $4.9B |
| Cash & Equivalents | $5.4B | $7.6B | $7.1B | $4.2B | $3.8B | $4.5B | $2.7B | $1.6B |
| Total Liabilities | $17.9B | $16.1B | $13.3B | $13.1B | $12.4B | $11.0B | $10.2B | $9.4B |
| Current Liabilities | $10.2B | $10.5B | $8.3B | $8.1B | $6.9B | $5.5B | $8.2B | $4.3B |
| Stockholders' Equity | $11.6B | $14.1B | $16.5B | $14.1B | $14.8B | $13.3B | $10.5B | $9.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.0B | $8.1B | $7.3B | $7.8B | $7.2B | $5.7B | $4.4B | $4.0B |
| Investing Cash Flow | $-1.2B | $0.1B | $0.8B | $-0.6B | $-3.5B | $-0.4B | $-0.5B | $-4.7B |
| Capital Expenditures | $0.2B | $0.2B | $0.4B | $0.4B | $0.3B | $0.4B | $0.4B | $0.3B |
| Financing Cash Flow | $-11.1B | $-7.7B | $-5.2B | $-6.8B | $-4.3B | $-3.5B | $-2.9B | $-0.0B |